Delivery Order SPE2DB20D7059-SPE2DB24FQCG8
- Not listed
- This federal contract award is a delivery order worth $11,235.72 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award has an ultimate completion date of September 24, 2024 and uses a firm fixed price pricing type. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,726.60, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,464.36 firm fixed-price delivery order contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This federal contract award, valued at $1,022.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a type of vaccine, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with an ultimate completion date of April 10, 2024. This...
- This federal contract award is a delivery order worth $10,342.25 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566788949 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a period of performance through December 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $23,407.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The award is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,171.00 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,978.12 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a period of performance through May 15, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, valued at $3,783.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of May 15, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,630.85 firm fixed price delivery order is for the supply of 4566866879 ! TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQCG8Delivery Order
This federal contract award, valued at $3,505.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for a firm fixed price delivery order to supply TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, in support of military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical. This specific delivery order was issued under that IDC. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 3/22/24 |